Regulation A+ (Reg A+) is a funding option that feels tailor-made for high impact technologies like medtech.
Never heard of it? That’s because it didn’t exist until 2015, when the Obama administration passed the JOBS Act. Before then, private companies could only seek backing from the wealthiest 2% of Americans — accredited investors. The new Reg A+ (think “reggae”) rules in Title IV enable small firms to raise money from all Americans in a sort of “mini-IPO.”
Read more HERE